Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD

Thorax

Volumn 65, Issue 11, 2010, Pages 963-970

  Doucet, Mariève ^a   Dubé, Annie ^a   Joanisse, Denis R ^a,b   Debigaré, Richard ^a   Michaud, Annie ^a   Paré, Marie Ève ^a   Vaillancourt, Rosaire ^a   Fréchette, Éric ^a   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR FKHR;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; LUNG FUNCTION; MALE; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; PROTEIN CONTENT; QUADRICEPS FEMORIS MUSCLE; SIGNAL TRANSDUCTION;

EID: 78149313458     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.133827     Document Type: Article

References (40)

1. Schols AM, Mostert R, Soeters PB, et al. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax 1989;44:937-41. (Pubitemid 19281536)
2. Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-67.
3. Marquis K, Debigaré R, LeBlanc P, et al. Mid-thigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Respir Crit Care Med 2002;166:809-13.
4. Bégin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:905-12.
5. Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:961-6. (Pubitemid 26081646)
6. Crul T, Spruit MA, Gayan-Ramirez G, et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007;37:897-904. (Pubitemid 350029204)
7. Debigaré R, Maltais F, Côté CH, et al. Profiling of mRNA expression in quadriceps of patients with copd using microarrays. COPD 2007;5:75-84.
8. Radom-Aizik S, Kaminski N, Hayek S, et al. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 2007;102:1976-84. (Pubitemid 46701970)
9. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008;31:492-501.
10. Reid MB. Response of the ubiquitin-proteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol 2005;288:R1423-31.
11. Zhang P, Chen X, Fan M. Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses 2007;69:310-21. (Pubitemid 46818689)
12. Solomon AM, Bouloux PM. Modifying muscle mass - the endocrine perspective. J Endocrinol 2006;191:349-60.
13. Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010;104:1005-11.
14. Doucet M, Russell AP, Léger B, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:261-9. (Pubitemid 47195876)
15. Plant PJ, Brooks D, Faughnan M, et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease (COPD). Am J Respir Cell Mol Biol 2010;42:461-71.
16. Ottenheijm CA, Heunks LM, Sieck GC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:200-5.
17. Ottenheijm CA, Heunks LM, Li YP, et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:997-1002. (Pubitemid 44684448)
18. Testelmans D, Crul T, Maes K, et al. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 2010;35:549-56.
19. Similowski T, Yan S, Gauthier AP, et al. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991;325:917-23.
20. Levine S, Kaiser L, Leferovich J, et al. Cellular adaptation in the diaphragm in chronic osbtructive pulmonary disease. N Engl J Med 1997;337:1799-806. (Pubitemid 28006784)
21. Mercadier JJ, Schwartz K, Schiaffino S, et al. Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol 1998;274:L527-34.
22. Doucet M, Debigaré R, Joanisse DR, et al. Adaptation of the diaphragm and the vastus lateralis muscle in mild to moderate COPD. Eur Respir J 2004;24:971-9. (Pubitemid 39642288)
23. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-120.
24. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
25. Heymsfield SB, Williams PJ, Shils ME, et al. Nutritional assessment by clinical and biochemical methods. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1994:812-41.
26. Maltais F, Leblanc P, Whittom F, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000;55:848-53.
27. Blomstrand E, Celsing F, Fridén J, et al. How to calculate human muscle fibre areas in biopsy samples-methodological considerations. Acta Physiol Scand 1984;122:545-51. (Pubitemid 15197448)
28. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold Executive Summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
29. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009;33:262-72.
30. Orozco-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J Suppl 2003;46:41s-51s.
31. 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 1996;316:65-72.
32. Degens H, Alway SE. Control of muscle size during disuse, disease, and aging. Int J Sports Med 2006;27:94-9. (Pubitemid 43288519)
33. Caron MA, Debigaré R, Dekhuijzen PN, et al. Comparative assessment of the quadriceps and the diaphragm in patients with copd. J Appl Physiol 2009;107:952-61.
34. Degens H, Swisher AK, Heijdra YF, et al. Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster. Am J Physiol Regul Integr Comp Physiol 2007;293:R135-44. (Pubitemid 47092171)
35. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-8. (Pubitemid 33104839)
36. Cho JE, Fournier M, Da X, et al. Time course expression of foxo transcription factors in skeletal muscle following corticosteroid administration. J Appl Physiol 2010;108:137-45.
37. Kamei Y, Miura S, Suzuki M, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004;279:41114-23. (Pubitemid 39287713)
38. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412. (Pubitemid 38534545)
39. Bossola M, Muscaritoli M, Costelli P, et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 2003;237:384-9. (Pubitemid 38176454)
40. Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIx atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-19.